Please use this identifier to cite or link to this item: http://hdl.handle.net/11189/7344
Title: Potentials of Phytotherapeutic Treatment of Erectile Dysfunction
Other Titles: Antioxidant-Antidiabetic Agents and Human Health
Authors: Aboua, Yapo Guillaume 
Manirafasha, Claudine 
Mosito, Boitumelo R. 
Van der Linde, Michelle 
Du Plessis, Stefan Stephanus 
Keywords: Phytotherapeutic Treatment;erectile dysfunction;libido;diabetes;chronic kidney disease
Issue Date: 2014
Publisher: INTEC Open Science
Source: Aboua, G., Manirafasha, C., Mosito, B. R. et al. 2014. Potentials of Phytotherapeutic Treatment of Erectile Dysfunction. (In: Antioxidant-Antidiabetic Agents and Human Health, Oluwafemi Oguntibeju, IntechOpen, [http://doi.org/10.5772/57174]
Abstract: Erectile dysfunction (ED) or (male) impotence is a sexual dysfunction characterized by the inability to develop or maintain an erection of the penis [1]. There are various underlying causes, such as a compromised cardiovascular system and diseases such as diabetes and chronic kidney disease (CKD), many of which are medically treatable. The causes of erectile dysfunction may be physiological or psychological [2]. Sexual function includes libido, penile erection, ejaculation, and orgasm. While each of these parameters may be of concern to an individual patient, the vast majority of men complain of ED. Testosterone deficiency frequently is associated with decreased libido and ED. ED is a clinical problem that is underdiagnosed, under-evaluated, and under-treated. The prevalence of ED increases with age, and it is associated with multiple medical conditions including diabetes, hypertension, and heart disease that also increase with age. ED is a highly prevalent and often underreported condition. The prevalence of ED varies in different countries and approximately 100 million men worldwide are estimated to be affected with ED. More than half of US men between the ages of 40 and 70 years are estimated to have ED. The worldwide ED prevalence in men with diabetes ranges from 27% to 75% and it is estimated that the prevalence of ED will double in the next 25 years [3]. There is a strong link between ED and atherosclerotic disease due to the fact that they share similar risk factors. In a study where patients referred for myocardial perfusion single-photon emission computed tomography were screened for ED with a questionnaire, it was found out that 54.8% of the patients had ED. Patients with ED showed more severe coronary heart disease. In diabetic patients, ED has been shown to predict silent coronary artery disease, and in asymptomatic men without cardiovascular risk factors or
URI: http://hdl.handle.net/11189/7344
ISBN: 978-953-51-1215-0
DOI: http://doi.org/10.5772/57174
Appears in Collections:HWSci - Books / Book Chapters

Files in This Item:
File Description SizeFormat 
Potentials of Phytotherapeutic Treatment.pdf356.09 kBAdobe PDFView/Open
Show full item record

Page view(s)

18
checked on Feb 9, 2021

Download(s)

10
checked on Feb 9, 2021

Google ScholarTM

Check

Altmetric


Items in Digital Knowledge are protected by copyright, with all rights reserved, unless otherwise indicated.